Cargando…
Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica
Injection of silica did not brake the resistance against MHV3 conferred to C57BL/6 mice by injection of C. parvum. However, silica itself had a marked protective effect against MHV3 infection that was maximal when injecting 1 mg 2 hrs before virus infection. The protective effect of silica was obser...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gustav Fischer Verlag · Stuttgart · New York. Published by Elsevier GmbH
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134485/ https://www.ncbi.nlm.nih.gov/pubmed/6325328 http://dx.doi.org/10.1016/S0171-2985(84)80144-8 |
_version_ | 1783517846937010176 |
---|---|
author | Schindler, L. Brücher, J. Kirchner, H. |
author_facet | Schindler, L. Brücher, J. Kirchner, H. |
author_sort | Schindler, L. |
collection | PubMed |
description | Injection of silica did not brake the resistance against MHV3 conferred to C57BL/6 mice by injection of C. parvum. However, silica itself had a marked protective effect against MHV3 infection that was maximal when injecting 1 mg 2 hrs before virus infection. The protective effect of silica was observed in a number of inbred mouse strains that differ in their relative resistance to MHV3 infection. No viral titers were observed in the spleen and liver of mice which had received MHV3 plus silica, whereas high titers were observed in the virus-infected controls. Injection of silica caused a marked decrease in the number of esterase-positive macrophages in the peritoneal wash-out population, that may be compatible with the possibility that the cause of the protection is the depletion of target cells for the viral infection. This latter effect, however, was short-lived and 24–48 hrs after injection of silica, high numbers of esterase-positive cells were again observed. This may explain why only little protection was observed when silica was administered 2 days before virus infection. |
format | Online Article Text |
id | pubmed-7134485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1984 |
publisher | Gustav Fischer Verlag · Stuttgart · New York. Published by Elsevier GmbH |
record_format | MEDLINE/PubMed |
spelling | pubmed-71344852020-04-08 Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica Schindler, L. Brücher, J. Kirchner, H. Immunobiology Article Injection of silica did not brake the resistance against MHV3 conferred to C57BL/6 mice by injection of C. parvum. However, silica itself had a marked protective effect against MHV3 infection that was maximal when injecting 1 mg 2 hrs before virus infection. The protective effect of silica was observed in a number of inbred mouse strains that differ in their relative resistance to MHV3 infection. No viral titers were observed in the spleen and liver of mice which had received MHV3 plus silica, whereas high titers were observed in the virus-infected controls. Injection of silica caused a marked decrease in the number of esterase-positive macrophages in the peritoneal wash-out population, that may be compatible with the possibility that the cause of the protection is the depletion of target cells for the viral infection. This latter effect, however, was short-lived and 24–48 hrs after injection of silica, high numbers of esterase-positive cells were again observed. This may explain why only little protection was observed when silica was administered 2 days before virus infection. Gustav Fischer Verlag · Stuttgart · New York. Published by Elsevier GmbH 1984-01 2011-11-08 /pmc/articles/PMC7134485/ /pubmed/6325328 http://dx.doi.org/10.1016/S0171-2985(84)80144-8 Text en © 1984 Gustav Fischer Verlag · Stuttgart · New York Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Schindler, L. Brücher, J. Kirchner, H. Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica |
title | Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica |
title_full | Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica |
title_fullStr | Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica |
title_full_unstemmed | Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica |
title_short | Protection of Mice against Infection with Mouse Hepatitis Virus Type 3 by Injection of Silica |
title_sort | protection of mice against infection with mouse hepatitis virus type 3 by injection of silica |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134485/ https://www.ncbi.nlm.nih.gov/pubmed/6325328 http://dx.doi.org/10.1016/S0171-2985(84)80144-8 |
work_keys_str_mv | AT schindlerl protectionofmiceagainstinfectionwithmousehepatitisvirustype3byinjectionofsilica AT brucherj protectionofmiceagainstinfectionwithmousehepatitisvirustype3byinjectionofsilica AT kirchnerh protectionofmiceagainstinfectionwithmousehepatitisvirustype3byinjectionofsilica |